Lepu Biopharma Co Ltd
HKEX:2157
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lepu Biopharma Co Ltd
HKEX:2157
|
CN |
Cash Flow Statement
Cash Flow Statement
Lepu Biopharma Co Ltd
| Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||
| Net Income |
0
|
(30)
|
0
|
(424)
|
0
|
|
| Depreciation & Amortization |
0
|
103
|
0
|
100
|
0
|
|
| Stock-Based Compensation |
0
|
19
|
0
|
4
|
0
|
|
| Other Non-Cash Items |
0
|
(343)
|
0
|
35
|
0
|
|
| Cash Interest Paid |
29
|
29
|
28
|
28
|
29
|
|
| Change in Working Capital |
(364)
|
20
|
(290)
|
93
|
(35)
|
|
| Cash from Operating Activities |
(364)
N/A
|
(251)
+31%
|
(290)
-16%
|
(196)
+32%
|
(35)
+82%
|
|
| Investing Cash Flow | ||||||
| Capital Expenditures |
(76)
|
(41)
|
(43)
|
(62)
|
(95)
|
|
| Other Items |
(75)
|
125
|
0
|
0
|
14
|
|
| Cash from Investing Activities |
(151)
N/A
|
84
N/A
|
147
+75%
|
(62)
N/A
|
(81)
-32%
|
|
| Financing Cash Flow | ||||||
| Net Issuance of Common Stock |
0
|
0
|
213
|
213
|
0
|
|
| Net Issuance of Debt |
311
|
20
|
(40)
|
96
|
143
|
|
| Other |
(33)
|
(96)
|
(98)
|
(77)
|
(74)
|
|
| Cash from Financing Activities |
278
N/A
|
(77)
N/A
|
75
N/A
|
232
+209%
|
69
-70%
|
|
| Change in Cash | ||||||
| Effect of Foreign Exchange Rates |
3
|
0
|
0
|
1
|
5
|
|
| Net Change in Cash |
(233)
N/A
|
(243)
-4%
|
(68)
+72%
|
(25)
+64%
|
(41)
-66%
|
|
| Free Cash Flow | ||||||
| Free Cash Flow |
(440)
N/A
|
(292)
+34%
|
(333)
-14%
|
(258)
+23%
|
(130)
+50%
|
|